Company news
Syntara Limited news in 2020
Syntara Limited's news releases, calls and decks from 2020, newest first.
Pharmaxis Receives US$7m milestone from Chiesi
December 29, 2020
Pharmaxis Prioritises Clinical Program on Myelofibrosis
November 1, 2020
September Quarter 2020 Activity Report
October 29, 2020
Boehringer Ingelheim discontinues development of BI 1467335
September 6, 2020
Pharmaxis Awarded $1M Australian Government Grant
September 2, 2020
FDA Gives Green Light to Start Myelofibrosis Phase 2 Study
August 19, 2020
US$7 million Bronchitol Launch Milestone Brought Forward
August 4, 2020
Fourth Quarter Activity Report
July 30, 2020
Pharmaxis Quarterly Shareholder Update - March 2020
April 29, 2020
PXS Cancer Drug Ready to Commence Phase 2 Studies Q4 2020
April 27, 2020
Quarterly Shareholder Update - December 2019
January 30, 2020